For this article:

5 Apr 2026·Source: The Hindu
2 min
Science & TechnologyNEWS

Light-Powered Microbes Revolutionize Drug and Chemical Production

Scientists are using light to activate enzymes in microbes like E. coli, creating efficient 'cell factories' for producing complex drugs and chemicals.

UPSC-PrelimsUPSC-Mains
Light-Powered Microbes Revolutionize Drug and Chemical Production

Photo by Microsoft Copilot

Quick Revision

1.

Photobiocatalysis uses light to trigger and accelerate enzyme reactions within microbes.

2.

Researchers have engineered bacteria like E. coli and yeast like Pichia pastoris to act as 'bioreactors' or 'cell factories'.

3.

These engineered microbes can efficiently synthesize complex and valuable products, including anti-cancer drugs (vinblastine, vincristine, Taxol precursor) and industrial polymers (pyridine dicarboxylate, styrene polymer).

4.

The process uses simple sugars like glucose as raw material.

5.

Light, including UV, visible, and blue light, serves as the energy source for these reactions.

6.

The approach combines biosynthesis with photo-biotechnology.

7.

This technology has the potential for large-scale chemical production.

8.

Research in this area is being conducted by institutions globally, including Nanjing University, Antaya University, Kobe University, DuPont, MIT, and the University of Illinois.

Key Dates

April 2025 (Organic Chemistry Frontiers publication)2023 (Nature Synthesis publication)2025 (Nature Chemical Biology publication)May 2007 (Metabolic Engineering publication)January 2026 (Nature Catalysis publication)

Key Numbers

12 (volume of Organic Chemistry Frontiers)16 (issue of Organic Chemistry Frontiers)2 (volume of Nature Synthesis)231-242 (pages of Nature Synthesis)21 (volume of Nature Chemical Biology)1171–1181 (pages of Nature Chemical Biology)9 (volume of Metabolic Engineering)3 (issue of Metabolic Engineering)9 (volume of Nature Catalysis)62-72 (pages of Nature Catalysis)

Mains & Interview Focus

Don't miss it!

The emergence of photobiocatalysis represents a significant inflection point in industrial biomanufacturing, moving beyond conventional chemical synthesis. This innovative approach, leveraging light to accelerate enzyme reactions within engineered microbes, offers a compelling pathway for the cost-effective and environmentally benign production of high-value compounds. India, with its robust biotechnology sector and a pressing need for sustainable industrial solutions, must strategically invest in this domain.

Historically, our pharmaceutical and chemical industries have relied heavily on energy-intensive, multi-step chemical processes, often generating substantial hazardous waste. This new paradigm, exemplified by the production of anti-cancer drugs like vinblastine and industrial polymers from simple sugars using E. coli, promises to drastically reduce the environmental footprint. It aligns with the national imperative for Green Chemistry and a circular economy, as outlined in various policy documents from the NITI Aayog and the Ministry of Environment, Forest and Climate Change.

However, scaling these laboratory successes to industrial production presents formidable challenges. While the article highlights the potential for 'large-scale chemical production,' issues of bioreactor design, light penetration efficiency in dense cultures, and downstream processing remain critical. Furthermore, regulatory frameworks for genetically engineered microbes, though established by bodies like the Genetic Engineering Appraisal Committee (GEAC), need to be agile enough to facilitate innovation while ensuring biosafety.

To capitalize on this, the Department of Biotechnology (DBT) and the Department of Science & Technology (DST) must prioritize funding for translational research and pilot projects. Establishing dedicated bio-manufacturing hubs, similar to those in Singapore or Germany, could foster collaboration between academia and industry. This would not only secure domestic supply chains for critical drugs but also position India as a leader in sustainable bio-manufacturing, attracting global investment and talent.

View Detailed Summary

Summary

Scientists are now using light to power tiny living organisms, like bacteria, to make important things such as medicines and plastics. This new method is cleaner and more efficient than traditional factories, using simple sugars as raw materials instead of harsh chemicals.

A process called 'photobiocatalysis' is gaining traction, where light is used to trigger and accelerate enzyme reactions within microbes. Researchers have successfully engineered bacteria like E. coli to act as 'bioreactors' or 'cell factories'.

By using light as an energy source, these microbes can efficiently synthesize complex and valuable products, such as anti-cancer drugs (vinblastine, vincristine) and industrial polymers, directly from simple sugars like glucose. This approach combines the precision of enzymes with the energy of light, opening new avenues for sustainable and scalable manufacturing.

Source Articles

RS

About the Author

Richa Singh

Science Policy Enthusiast & UPSC Analyst

Richa Singh writes about Science & Technology at GKSolver, breaking down complex developments into clear, exam-relevant analysis.

View all articles →